TY - JOUR
T1 - Analgesic Effects of Vagus Nerve Stimulation on Visceral Hypersensitivity
T2 - A Direct Comparison Between Invasive and Noninvasive Methods in Rats
AU - Guo, Yu
AU - Gharibani, Payam
N1 - Publisher Copyright:
© 2023 International Neuromodulation Society
PY - 2024/2
Y1 - 2024/2
N2 - Objectives: The aims of this study were to investigate analgesic effects of vagus nerve stimulation (VNS) on visceral hypersensitivity (VH) in a rodent model of functional dyspepsia (FD) and to compare invasive VNS with noninvasive auricular VNS (aVNS). Materials and Methods: Eighteen ten-day-old male rats were gavaged with 0.1% iodoacetamide (IA) or 2% sucrose solution for six days. After eight weeks, IA-treated rats were implanted with electrodes for VNS or aVNS (n = 6 per group). Different parameters, varying in frequency and stimulation duty cycle, were tested to find the best parameter based on the improvement of VH assessed by electromyogram (EMG) during gastric distension. Results: Compared with sucrose-treated rats, visceral sensitivity was increased significantly in IA-treated “FD” rats and ameliorated remarkably by VNS (at 40, 60, and 80 mm Hg; p ≤ 0.02, respectively) and aVNS (at 60 and 80 mm Hg; p ≤ 0.05, respectively) with the parameter of 100 Hz and 20% duty cycle. There was no significant difference in area under the curve of EMG responses between VNS and aVNS (at 60 and 80 mm Hg, both p > 0.05). Spectral analysis of heart rate variability revealed a significant enhancement in vagal efferent activity while applying VNS/aVNS compared with sham stimulation (p < 0.01). In the presence of atropine, no significant differences were noted in EMG after VNS/aVNS. Naloxone blocked the analgesic effects of VNS/aVNS. Conclusions: VNS/aVNS with optimized parameter elicits ameliorative effects on VH, mediated by autonomic and opioid mechanisms. aVNS is as effective as direct VNS and has great potential for treating visceral pain in patients with FD.
AB - Objectives: The aims of this study were to investigate analgesic effects of vagus nerve stimulation (VNS) on visceral hypersensitivity (VH) in a rodent model of functional dyspepsia (FD) and to compare invasive VNS with noninvasive auricular VNS (aVNS). Materials and Methods: Eighteen ten-day-old male rats were gavaged with 0.1% iodoacetamide (IA) or 2% sucrose solution for six days. After eight weeks, IA-treated rats were implanted with electrodes for VNS or aVNS (n = 6 per group). Different parameters, varying in frequency and stimulation duty cycle, were tested to find the best parameter based on the improvement of VH assessed by electromyogram (EMG) during gastric distension. Results: Compared with sucrose-treated rats, visceral sensitivity was increased significantly in IA-treated “FD” rats and ameliorated remarkably by VNS (at 40, 60, and 80 mm Hg; p ≤ 0.02, respectively) and aVNS (at 60 and 80 mm Hg; p ≤ 0.05, respectively) with the parameter of 100 Hz and 20% duty cycle. There was no significant difference in area under the curve of EMG responses between VNS and aVNS (at 60 and 80 mm Hg, both p > 0.05). Spectral analysis of heart rate variability revealed a significant enhancement in vagal efferent activity while applying VNS/aVNS compared with sham stimulation (p < 0.01). In the presence of atropine, no significant differences were noted in EMG after VNS/aVNS. Naloxone blocked the analgesic effects of VNS/aVNS. Conclusions: VNS/aVNS with optimized parameter elicits ameliorative effects on VH, mediated by autonomic and opioid mechanisms. aVNS is as effective as direct VNS and has great potential for treating visceral pain in patients with FD.
KW - Functional gastrointestinal disorders
KW - vagus nerve stimulation
KW - visceral pain
UR - http://www.scopus.com/inward/record.url?scp=85159263058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159263058&partnerID=8YFLogxK
U2 - 10.1016/j.neurom.2023.04.001
DO - 10.1016/j.neurom.2023.04.001
M3 - Article
C2 - 37191611
AN - SCOPUS:85159263058
SN - 1094-7159
VL - 27
SP - 284
EP - 294
JO - Neuromodulation
JF - Neuromodulation
IS - 2
ER -